Private Placement

Current blood thinners carry a risky trade-off. A new class of drugs targeting Factor XIa could prevent deadly clots without the dangerous bleeding.

Novo Nordisk exec Karin Conde-Knape joins Valo as CSO, signaling a major validation for AI's role in creating next-generation medicines.

The Trump Administration has unveiled a $12 billion strategic mineral stockpile to break reliance on China and secure the future of American manufacturing.

A new binational challenge offers $70,000 in funding, calling on students and entrepreneurs to build the next wave of water technology solutions.

Osisko Development hires a regulatory powerhouse, signaling a strategic push to de-risk its path to gold production amid rising environmental scrutiny.

Palomar Holdings finalizes its Gray Surety acquisition, backed by a new $450M credit facility, in a bold strategic move to challenge specialty insurance leaders.

As Mark Adams retires, Penguin Solutions appoints Kash Shaikh, a proven AI and SaaS leader, to accelerate its push into the booming enterprise AI market.

As Canada observes the 30th anniversary of Black History Month, a look at its origins, the icons it honours, and its vision for the future.

From AI brains to spider silk armor, the 'Ironman Economy' is more than a metaphor. But who are the real players and what is the actual investment case?

A looming federal tax credit deadline threatens solar projects. NuGen Capital's strategic investment aims to save distressed assets and stabilize the grid.

The firm's major investment in VA and NC blends value-add buys with new builds, navigating complex local markets to chase regional growth.

vTv Therapeutics shores up its finances with a deal worth up to $135M, sharpening its focus on a breakthrough Type 1 diabetes drug, cadisegliatin.

Ensem Therapeutics expands its global trial for ETX-636, a next-gen cancer drug designed to avoid common toxicities, into China's vast patient market.

With a major Phase 3 trial now in Europe, Crystalys Therapeutics aims to fill a critical gap in gout care with a drug already proven in Asian markets.

With an extra $3M, Aduro Clean Technologies advances its game-changing plant, turning investor confidence into a reality for recycling and energy.

NurExone appoints Eyal Gabbai, a healthcare and finance heavyweight, to its board, signaling a strategic pivot from R&D to market execution for its therapies.

Shane Kovacs's exit from Olema Oncology introduces leadership questions as the biotech firm nears a pivotal data readout for its lead breast cancer drug.

Legendary investor Eric Sprott injects $40M into Highlander Silver, fueling its world-class San Luis project and signaling a major move in the silver market.

Known for luxury hotels and cigars, Zaya Younan is now building one of California's largest solar plants. A visionary pivot or a high-stakes gamble?

Asante Gold boosts its war chest with a C$13.8M private placement led by its own chairman, fueling aggressive expansion at its Ghanaian gold mines.